CD44 and pachyonychia congenita: Immunoexpression of the CD44+/CD24− phenotype was directly correlated to PC cases with higher Gleason scores and shorter patient survival times, reflecting a proliferative, tumorigenic, metastatic, and resistant to chemotherapy and in vivo radiotherapy phenotype [77,80,81].